@article {341, title = {The Home Care Clinical Pharmacy Practice in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {December 2022}, pages = {122-131}, type = {Research Article }, chapter = {122}, abstract = {

Objectives: To demonstrate the clinical pharmacy in home health care services in Saudi Arabia. Methods: It analyzes a cross-sectional survey discussing home care clinical pharmacy practice in Saudi Arabia. The survey consisted of respondents{\textquoteright} demographic information about the workforce{\textquoteright}s pharmacists, Pharmacotherapy classes utilization for home healthcare patients, and therapeutic guidelines implemented in Home Healthcare Pharmacy services. The 5-point Likert response scale system was used with closed-ended questions. The survey was validated through the revision of expert reviewers and pilot testing. Besides, various tests of reliability, McDonald{\textquoteright}s ω, Cronbach alpha, Gutmann{\textquoteright}s λ2, and Gutmann{\textquoteright}s λ6 were done with the study. Furthermore, the data analysis of the home care clinical pharmacy practice is done through the survey monkey system. Besides, the statistical package of social sciences (SPSS), Jeffery{\textquoteright}s Amazing Statistics Program (JASP), and Microsoft Excel sheet version 16. Results: A total number of 393 pharmacists responded to the questionnaire. Of them, more than three-quarters responded from the Central region (303 (77.10\%)), with statistically significant differences between the provinces (p=0.000). Males responded less than females (195 (49.74\%)) versus 197 (50.26\%\%)), with statistically non-significant differences between them (p=0.920). Most of the responders were in the age group of 24-35 years (267 (67.94\%)) and 36-45 years (121 (30.79\%)), with statistically significant differences between all age groups (p=0.000). Most responders stated that pharmacy home healthcare workforces were five or more clinical pharmacists (35.14-41.89\%) and full-time pharmacy staff providing home health pharmacy services. Besides, five or more pharmacists (30.89-52.57\%) and five or more pharmacy technicians (31.25-51.09\%) with statistically significant differences between all workforce numbers (p=0.000). Most medications reviewed or dispensed for home healthcare patients include Nutrition support (4.50) and Vitamins and mineral supplements (4.49). They were followed by NSAIDs or Pain killers (4.46) and Antibiotics (4.45), with statistically significant differences between all answers (p=0.000). The average score of therapeutic guidelines implemented in Home healthcare Pharmacy services was (4.29). The element {\textquotedblleft}The standard considerations of urology disease therapy guidelines{\textquotedblright} obtained the highest score (4.44). The element {\textquotedblleft}The standard considerations of acute and chronic kidney disease therapy among geriatric patients{\textquotedblright} was (4.41), and the aspect {\textquotedblleft}The concerns and management of Gastrointestinal therapeutic guidelines{\textquotedblright} was (4.38). Conclusion: Nutrition support and vitamin were most used as pharmacotherapy classes for home healthcare services. The urology and nephrology therapeutic guidelines were most implemented. Future research is needed to determine most home care clinical pharmacy services and identify the role of clinical practitioners in home health care services in Saudi Arabia

}, keywords = {Clinical, Home Healthcare, Pharmacy, Practice, Saudi Arabia, Services}, doi = {10.5530/ijpcs.2022.11.19}, author = {Yousef Ahmed Alomi and Ghorm Allah Abdullah Aghamdi and Areej Abdullah Al Jasser and Maha Hussein Almadany and Hussa Mubarak Muwainea and Abeer Hussin Almasoudi and Osama Ali Alzahrani} } @article {324, title = {Research Policy of the Research Data Management in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {20-24}, type = {Review Article}, chapter = {20}, abstract = {

Objectives: This study aims to declare the research policy of Data management in pharmaceutical care services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the Research policy of Data management in pharmaceutical care services. Results: The data management policy for research at pharmaceutical care services was established. That includes the design of the data collection, the data resources, and the data collector. Additionally, the data preparation for analysis, the data{\textquoteright}s reliability and validity, and storage data. Conclusion: The Data management policy for research in pharmacy practice is a new initiative as part of pharmacy departments{\textquoteright} research and development efforts. Data management in pharmacy care services may increase the documentation of pharmacist research and activities. The basic foundation of pharmacy analytics is the new vision of pharmacy career professionals.

}, keywords = {Data management, Pharmaceutical Care, Policy, Research, Saudi Arabia, Services}, doi = {10.5530/ijpcs.2022.11.5}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {294, title = {Forensic Pharmacy Practice: New Initiatives in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {10}, year = {2021}, month = {September 2021}, pages = {89-91}, type = {Review Article}, chapter = {89}, abstract = {

Objectives: To explore the services provided by the forensic pharmacy as the new initiative in the Kingdom of Saudi Arabia. Methods: This is a new project derived from the national and international forensic pharmacy services guidelines. The project has been formulated from the global business model, which is the pharmacy project guidelines of the new project. The initial project is written by the project management professional. It consisted of the initial and planning phase, the execution phase, and the monitoring and controlling phase. Results: The scope of forensic pharmacy services was explored with a defined vision, mission, and goals. The services revealed clinical and economic benefits to the patients. The risk management model assures the continuation of the project. Moreover, the monitoring and controlling of the forensic services as declared. Finally, the project{\textquoteright}s transition from the operation phase to the closing phase has been explored in this study. Conclusion: The forensic pharmacy practice is a new initiative project, and it was among the pharmacy strategic plan. The forensic pharmacy services were found to meet the requirement of the forensic pharmacy workforces, overcome the requirement of pharmacy services, and improve forensic clinical pharmacy staff. Therefore, it highly suggests implementing forensic pharmacy services in Saudi Arabia.

}, keywords = {Forensic pharmacy, Initiative, Practice, Saudi Arabia, Services}, doi = {10.5530/ijpcs.2021.10.13}, author = {Yousef Ahmed Alomi and Rehab Sultan Najmi and Abeer Hussin Almasoudi} } @article {295, title = {Nuclear Pharmacy Practice: New Initiatives in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {10}, year = {2021}, month = {September 2021}, pages = {47-50}, type = {Review Article}, chapter = {47}, abstract = {

Objectives: To declare the nuclear pharmacy services in the Kingdom of Saudi Arabia. Methods: It is a new initiative project derived through the international nuclear pharmacy services guidelines. The project has been formulated from the global business model and pharmacy project guidelines of a new project. Various project management tools write the new project. It consists of the initial and planning phases, the execution phase, and the monitoring and controlling phase. Results: The project presents nuclear pharmacy services with a defined vision, mission, and goals. The nuclear pharmacy services showed various benefits, including clinical and economic benefits to the patient. The risk management model description assured the continuation of the project. Moreover, the monitoring and controlling of the services were explored. Finally, the transition to operation project through the closing project stage is explored in the analysis. Conclusion: The nuclear pharmacy services is a new initiative project in the Kingdom of Saudi Arabia. It includes a pharmacy strategy in Saudi Vision 2030. The nuclear pharmacy services required the pharmacy workforces, all requirements of basic nuclear pharmacy services foundations. Therefore, the implementation of nuclear clinical pharmacy services is highly suggested in Saudi Arabia.

}, keywords = {Initiative, Nuclear, Pharmacy, Practice, Saudi Arabia, Services}, doi = {10.5530/ijpcs.2021.10.8}, author = {Yousef Ahmed Alomi and Rehab Sultan Najmi and Abeer Hussin Almasoudi} }